MHNC
Maiden Holdings North America, Ltd.
There isn't enough reported data to score MHNC yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
MHNC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| N/A | |
| N/A |
MHNC's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like MHNC.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
MHNC PE Valuation
MHNC has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
MHNC Forward outlook
There aren't enough analyst estimates for MHNC to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
MHNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.11 | +$0.15 |
| Q4 2024 | -$0.01 | +$0.37 |
| Q3 2024 | -$0.65 | +$0.33 |
| Q2 2024 | -$0.33 | +$0.71 |
| Q1 2024 | -$0.26 | +$0.46 |
| Q4 2023 | -$0.38 | +$0.25 |
| Q3 2023 | -$0.98 | -333% |
| Q2 2023 | -$1.04 | -317% |
MS has the stronger earnings trend. Trailing diluted EPS is down 142% for MHNC versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
MHNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $14M | -51% |
| Q3 2024 | $14.5M | -33% |
| Q2 2024 | $20.5M | -10% |
| Q1 2024 | $28.9M | +48% |
| Q4 2023 | $25.2M | +160% |
| Q3 2023 | $21.8M | +23% |
| Q2 2023 | $22.8M | +10% |
| Q1 2023 | $19.5M | +94% |
MS has the stronger quarterly revenue trend. Revenue is down 51% for MHNC versus up 12% for MS.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | -42% | -45 points |
| Q3 2024 | -243% | -217 points |
| Q2 2024 | -54% | -19 points |
| Q1 2024 | 3% | +61 points |
| Q4 2023 | -84% | +471 points |
| Q3 2023 | -26% | +18 points |
| Q2 2023 | -35% | -51 points |
| Q1 2023 | -58% | -39 points |
MHNC's operating margin was −42% last quarter, up 42 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
MHNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2025 | -$21.1M | -362% |
| Q4 2024 | $102M | +1540% |
| Q3 2024 | -$3.8M | -$1.5M |
| Q2 2024 | -$23.4M | +$19.9M |
| Q1 2024 | $8M | +$28.4M |
| Q4 2023 | $6.2M | +$102.3M |
| Q3 2023 | -$2.3M | +$8.7M |
| Q2 2023 | -$43.3M | -$30.6M |
MHNC has the stronger cash trend. Its trailing FCF is up 114% versus its history, compared with MS at down 492%.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
MHNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -782K shares |
| 1 year | -1.3% | -1.3M shares |
| 3 years | +15% | +12.6M shares |
| 5 years | +19% | +16.1M shares |
| Available history | +19% | +16M shares |
MHNC has 99M diluted shares, down 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | $1.2M |
| Q3 2024 | $641,000 |
| Q2 2024 | $1.8M |
| Q1 2024 | $673,000 |
| Q4 2023 | $1M |
| Q3 2023 | $1.1M |
| Q2 2023 | $533,000 |
MHNC spent $4M buying back its own shares over the past year, up 10% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over MHNC on shareholder dilution, with a more favorable share count trend.
MHNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 41.8x | High |
| Q2 2022 | 18.0x | High |
| Q1 2022 | 13.8x | High |
| Q4 2021 | 8.4x | High |
| Q3 2021 | 7.9x | High |
| Q2 2021 | 6.2x | High |
| Q1 2021 | 4.5x | High |
| Q4 2020 | 3.6x | Elevated |
MHNC's net debt is more than 20 years of its operating earnings (EBITDA), up from 7.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MHNC.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
MHNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 28.3 | Neutral |
MHNC's weekly RSI is 38 (neutral) and its Stochastic is 28 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
MHNC PE vs Financial Services Sector
| Metric | MHNC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MHNC has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
MHNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 0% above |
| 20 week MA | $11.3 | 5.9% below |
| 50 week MA | $13.0 | 18% below |
| 100 week MA | $15.0 | 29% below |
| 200 week MA | $16.4 | 35% below |
MHNC is in a downtrend: it's below all five of its weekly moving averages, and 35% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over MHNC on trend strength, trading above more of its moving averages.
MHNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.2 | $22.2 | -0.1% |
| 2021 | $22.2 | $22.6 | +2% |
| 2022 | $22.6 | $18.4 | -19% |
| 2023 | $18.4 | $19.0 | +3.3% |
| 2024 | $19.0 | $17.0 | -11% |
| 2025 | $17.0 | $15.8 | -7.4% |
| 2026 YTD | $15.8 | $10.6 | -33% |
MHNC has finished lower in four of the last six years. It's down 33% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over MHNC on returns for 2026, with the stronger performance.